Document is current
Any future updates will be listed below
-
Authors
Kang, Da-Young
Cho, Kyung-Jae
Kwon, Oyeon
Kwon, Joon-myoung https://orcid.org/0000-0001-6754-1010
Jeon, Ki-Hyun
Park, Hyunho
Lee, Yeha
Park, Jinsik
Oh, Byung-Hee
-
Funding
Funding for this research was provided by:
Ministry of Trade, industry & Energy (2000486,)
- License Information
-
More Information
Article History
Received: 12 December 2019
Accepted: 21 February 2020
First Online: 4 March 2020
Ethics approval and consent to participate
: The institutional review boards of Sejong General Hospital (2019–0212) and Mediplex Sejong Hospital (2019–049) approved this study protocol and waived the need for informed consent because of the impracticality and minimal harm involved.
: Not applicable.
: VUNO provided support in the form of salaries for the authors (Kyung-Jae Cho, Oyeon Kwon, Hyunho Park, and Yeha Lee), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Yeha Lee is the co-founder and stakeholder in VUNO Inc., a medical artificial intelligence company. Mr. Kyung-Jae Cho, Oyeon Kwon, and Hyunho Park, are employees of VUNO Inc. Mr. There are no patents, products in development, or marketed products to declare. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
